Thus, novel strategies that can preserve beta-cell integrity improve insulin sensitivity, and counteract inflammatory mediators like NF-κB, TNF-α, and JNK would be useful in the prevention and management of insulin resistant T2D and related cardiometabolic complications. The gene discussed is MAPK8; the disease is type 2 diabetes mellitus.